Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.93 EUR | -4.46% |
|
-9.81% | -27.44% |
04-08 | Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-25 | Advicenne: ODD designation in cystinuria | CF |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 71.17 | 84.19 | 94.11 | 45.4 | 32.68 | 23.71 | - |
Enterprise Value (EV) 1 | 54.99 | 81.21 | 93.96 | 55.83 | 45.13 | 46.41 | 20.51 |
P/E ratio | -5.06 x | -5.68 x | -7.1 x | -3.94 x | -3.97 x | -3.02 x | 0.94 x |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | 27.5 x | 23.6 x | 28.5 x | 19.4 x | 11.1 x | 5.64 x | 4.12 x |
EV / Revenue | 21.3 x | 22.8 x | 28.5 x | 23.8 x | 15.3 x | 11 x | 3.57 x |
EV / EBITDA | -4.01 x | -5.83 x | -7.82 x | -5.74 x | -7.23 x | -7.87 x | 0.77 x |
EV / FCF | -5.28 x | - | - | -6.03 x | -6.21 x | -4.64 x | 0.98 x |
FCF Yield | -18.9% | - | - | -16.6% | -16.1% | -21.5% | 102% |
Price to Book | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 8,088 | 8,419 | 9,885 | 9,934 | 12,287 | 12,283 | - |
Reference price 2 | 8.800 | 10.00 | 9.520 | 4.570 | 2.660 | 1.930 | 1.930 |
Announcement Date | 20-03-13 | 21-04-28 | 22-03-31 | 23-03-30 | 24-03-28 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales 1 | 2.584 | 3.564 | 3.3 | 2.341 | 2.942 | 4.2 | 5.75 |
EBITDA 1 | -13.71 | -13.92 | -12.02 | -9.725 | -6.246 | -5.9 | 26.75 |
EBIT 1 | -14.25 | -14.14 | -12.44 | -10.06 | -6.457 | -6.3 | 10.3 |
Operating Margin | -551.39% | -396.63% | -377.09% | -429.69% | -219.48% | -150% | 179.13% |
Earnings before Tax (EBT) | - | - | - | - | - | - | - |
Net income 1 | -13.71 | -14.85 | -12.43 | -11.47 | -7.031 | -7.9 | 22.3 |
Net margin | -530.75% | -416.55% | -376.58% | -489.96% | -238.99% | -188.1% | 387.83% |
EPS 2 | -1.740 | -1.760 | -1.340 | -1.160 | -0.6700 | -0.6400 | 2.060 |
Free Cash Flow 1 | -10.41 | - | - | -9.262 | -7.271 | -10 | 20.95 |
FCF margin | -402.86% | - | - | -395.64% | -247.14% | -238.1% | 364.35% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | 78.32% |
FCF Conversion (Net income) | - | - | - | - | - | - | 93.95% |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 20-03-13 | 21-04-28 | 22-03-31 | 23-03-30 | 24-03-28 | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | 10.4 | 12.5 | 22.7 | - |
Net Cash position 1 | 16.2 | 2.97 | 0.15 | - | - | - | 3.2 |
Leverage (Debt/EBITDA) | - | - | - | -1.072 x | -1.993 x | -3.847 x | - |
Free Cash Flow 1 | -10.4 | - | - | -9.26 | -7.27 | -10 | 21 |
ROE (net income / shareholders' equity) | -58.9% | - | -694% | - | - | - | 372% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | 177% |
Assets 1 | - | - | - | - | - | - | 12.6 |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex 1 | 0.93 | - | - | 0.12 | 1.28 | 1 | 0.75 |
Capex / Sales | 35.99% | - | - | 4.91% | 43.58% | 23.81% | 13.04% |
Announcement Date | 20-03-13 | 21-04-28 | 22-03-31 | 23-03-30 | 24-03-28 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.44% | 25.4M | |
+2.99% | 95.18B | |
-4.34% | 37.55B | |
-10.41% | 33.75B | |
+75.79% | 28.2B | |
-14.61% | 15.63B | |
-3.46% | 13.63B | |
-12.31% | 11.5B | |
+184.77% | 10.81B | |
-54.13% | 9.23B |
- Stock Market
- Equities
- ALDVI Stock
- Financials Advicenne